US Patent Issued to TELIOS PHARMA on Sept. 16 for "Methods of treating indolent systemic mastocytosis" (California, Florida Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,950, issued on Sept. 16, was assigned to TELIOS PHARMA INC. (Redwood City, Calif.).

"Methods of treating indolent systemic mastocytosis" was invented by Wayne Rothbaum (Delray Beach, Fla.) and Reg Myers (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Therapeutic methods and pharmaceutical compositions for treating indolent systemic mastocytosis (ISM) in a human subject are described. In certain embodiments, the disclosure includes therapeutic methods of treating ISM using a BTK inhibitor. The disclosure also includes therapeutic methods of reducing or alleviating symptoms of ISM in a human subject."

The patent was filed on Nov...